BetterLife Pharma (BETRF) Change in Intangibles (2020 - 2021)
BetterLife Pharma (BETRF) posted quarterly Change in Intangibles of $809.17 for Q1 2021, up 11.1% quarter-over-quarter from $728.35 in Q4 2020.
BetterLife Pharma (BETRF) Change in Intangibles (2020 - 2021) Analysis & Trends
BetterLife Pharma's Change in Intangibles history runs 2 years deep, the most recent figure standing at $809.17 for Q1 2021.
- In Q1 2021, Change in Intangibles changed N/A year-over-year to $809.17; the TTM figure through Jan 2021 stood at -$62854.9 (changed N/A YoY), while the FY2021 annual figure was -$64681.8, changed N/A from the prior year.
- Change in Intangibles for Q1 2021 stood at $809.17, up from $728.35 in the prior quarter.
- The five-year high for Change in Intangibles was $809.17 in Q1 2021, with the low at -$62948.7 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.68 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2021 | 809.17 |
| Jan 31, 2021 | 809.17 |
| Oct 31, 2020 | 728.35 |
| Oct 31, 2020 | 728.35 |
| Jul 31, 2020 | -1,443.67 |
| Jul 31, 2020 | -1,443.67 |
| Apr 30, 2020 | -62,948.71 |
| Apr 30, 2020 | -62,948.71 |